
  
    
      
        Background_NNP
        Development_NNP of_IN the_DT male_JJ genitalia_NN is_VBZ largely_RB controlled_VBN
        by_IN cells_NNS in_IN the_DT urogenital_NN mesenchyme_NN that_WDT express_VBP androgen_NN
        receptors_NNS (_( AR_NNP )_) [_NN 1_CD 2_CD ]_NN ._. Germline_NNP mutations_NNS of_IN the_DT 
        AR_NNP gene_NN produce_VBP a_DT spectrum_NN of_IN
        developmental_NN abnormalities_NNS in_IN 46_CD ,_, XY_NNP individuals_NNS ranging_VBG
        from_IN infertility_NN or_CC mild_JJ hypospadias_NNS to_TO complete_VB
        feminization_NN ,_, which_WDT are_VBP collectively_RB referred_VBN to_TO as_IN the_DT
        androgen_NN insensitivity_NN syndrome_NN (_( AIS_NNP )_) ._. In_IN general_JJ ,_, the_DT
        degree_NN of_IN genital_JJ ambiguity_NN correlates_NNS with_IN the_DT level_NN of_IN
        compromise_NN of_IN AR_NNP function_NN :_: 46_CD ,_, XY_NNP individuals_NNS with_IN
        AR-inactivating_NNP mutations_NNS are_VBP completely_RB feminized_JJ despite_IN
        high_JJ levels_NNS of_IN serum_NN testosterone_NN [_NN 3_CD 4_CD 5_CD ]_NN ._.
        The_DT molecular_JJ events_NNS responsible_JJ for_IN AR-dependent_NNP male_JJ
        genital_JJ morphogenesis_NNS are_VBP poorly_RB understood_VBN ._. We_PRP
        hypothesized_VBN that_IN the_DT AR-dependent_NNP mesenchymal_NN programs_NNS
        underlying_VBG male_JJ external_JJ genitalia_NN development_NN might_MD be_VB
        illuminated_JJ by_IN comparing_VBG the_DT transcriptional_NN profile_NN of_IN
        mesenchyme-derived_JJ stromal_NN cells_NNS from_IN normal_JJ males_NNS to_TO those_DT
        from_IN individuals_NNS affected_VBN with_IN AIS_NNP ._. As_IN cultured_JJ genital_JJ
        fibroblasts_NNS originate_VB from_IN the_DT urogenital_NN mesenchyme_NN and_CC
        retain_VB expression_NN of_IN the_DT AR_NNP 
        in_IN vitro_NN ,_, we_PRP compared_VBD
        gene-expression_JJ patterns_NNS in_IN cultured_JJ genital_JJ fibroblasts_NNS
        from_IN normal_JJ 46_CD ,_, XY_NNP males_NNS and_CC from_IN 46_CD ,_, XY_NNP females_NNS with_IN severe_JJ
        or_CC complete_JJ AIS_NNP ,_, using_VBG DNA_NNP microarrays_NNS representing_VBG 32_CD ,_, 968_CD
        distinct_JJ human_JJ genes_NNS ._. We_PRP found_VBD striking_JJ differences_NNS in_IN the_DT
        gene_NN expression_NN profiles_NNS of_IN genital_JJ fibroblasts_NNS cultured_JJ
        from_IN normal_JJ and_CC AIS_NNP patients_NNS ,_, but_CC no_DT transcriptional_NN
        response_NN to_TO androgen_NN was_VBD detectable_JJ in_IN any_DT of_IN the_DT cultured_JJ
        genital_JJ fibroblasts_NNS ._.
      
      
        Results_NNS
        
          Baseline_NNP gene_NN transcription_NN in_IN genital_JJ
          fibroblasts_NNS
          To_TO gain_VB insights_NNS into_IN the_DT role_NN of_IN androgen_NN in_IN genital_JJ
          morphogenesis_NNS ,_, we_PRP compared_VBD basal_NN transcriptional_NN patterns_NNS
          in_IN genital_JJ fibroblasts_NNS from_IN 46_CD ,_, XY_NNP individuals_NNS with_IN either_DT
          wild-type_JJ AR_NNP or_CC germline_NN inactivation_NN of_IN the_DT AR_NNP as_IN a_DT
          result_NN of_IN mutation_NN ._. We_PRP could_MD not_RB identify_VB mutations_NNS in_IN
          the_DT 
          AR_NNP gene_NN in_IN two_CD phenotypically_RB
          female_JJ individuals_NNS with_IN complete_JJ AIS_NNP ._. However_RB ,_, genital_JJ
          skin_NN fibroblasts_NNS of_IN both_DT subjects_NNS failed_VBD to_TO express_VB AR_NNP
          protein_NN and_CC did_VBD not_RB show_VB androgen_NN binding_JJ (_( Table_NNP 1_LS )_) ._.
          Initially_RB ,_, we_PRP restricted_VBD our_PRP$ analysis_NN to_TO genital_JJ skin_NN
          fibroblasts_NNS grown_VBN from_IN the_DT foreskin_NN of_IN nine_CD normal_JJ males_NNS
          and_CC from_IN the_DT labia_NN majora_NN of_IN five_CD AIS-affected_NNP ,_, 46_CD ,_, XY_NNP
          individuals_NNS with_IN female_JJ external_JJ genitalia_NN ._. The_DT AR_NNP status_NN
          of_IN all_DT genital_JJ fibroblasts_NNS was_VBD confirmed_VBN by_IN 
          AR_NNP gene_NN sequencing_VBG and_CC
          hormone-binding_JJ assays_NNS (_( Table_NNP 1_LS )_) ._. To_TO determine_VB basal_NN
          gene-expression_JJ patterns_NNS ,_, mRNA_NN was_VBD isolated_VBN from_IN
          growth-arrested_JJ (_( G_NNP 
          0_CD )_) confluent_NN cells_NNS and_CC analyzed_VBD using_VBG
          DNA_NNP microarrays_NNS of_IN approximately_RB 43_CD ,_, 000_CD cDNAs_NNS
          representing_VBG 32_CD ,_, 968_CD genes_NNS ._. Distinct_NNP differences_NNS in_IN the_DT
          basal_NN expression_NN profiles_NNS of_IN normal_JJ and_CC AIS-derived_NNP
          fibroblasts_NNS allowed_VBD these_DT two_CD groups_NNS to_TO be_VB distinguished_VBN
          on_IN the_DT basis_NN of_IN their_PRP$ expression_NN patterns_NNS by_IN unsupervised_JJ
          hierarchical_JJ clustering_VBG analysis_NN (_( Figure_NN 1_LS )_) ._. We_PRP then_RB
          identified_VBD 404_CD unique_JJ transcripts_NNS (_( represented_VBN by_IN 487_CD
          total_JJ cDNAs_NNS )_) with_IN significant_JJ differences_NNS in_IN expression_NN
          levels_NNS between_IN normal_JJ and_CC AIS_NNP genital_JJ fibroblasts_NNS using_VBG
          the_DT significance_NN analysis_NN of_IN microarrays_NNS (_( SAM_NNP )_) -_: procedure_NN
          [_NN 6_CD ]_NN ,_, with_IN a_DT false_JJ discovery_NN rate_NN of_IN less_JJR than_IN 0_CD ._. 92_CD %_NN
          (_( percent_NN of_IN genes_NNS identified_VBN by_IN chance_NN alone_RB )_) ._.
          We_PRP used_VBD the_DT list_NN of_IN the_DT 487_CD cDNAs_NNS from_IN the_DT SAM_NNP
          analysis_NN for_IN hierarchical_JJ clustering_VBG analysis_NN of_IN 24_CD
          different_JJ primary_JJ fibroblast_NN lines_NNS from_IN normal_JJ and_CC AIS_NNP
          affected_VBD individuals_NNS (_( Figure_NN 2_LS )_) ._. In_IN addition_NN to_TO the_DT 14_CD
          genital-skin_JJ fibroblast_NN lines_NNS used_VBN to_TO generate_VB the_DT SAM_NNP
          list_NN ,_, we_PRP included_VBD five_CD gonadal_NN fibroblast_NN lines_NNS from_IN
          46_CD ,_, XY_NNP females_NNS with_IN complete_JJ AIS_NNP ,_, a_DT prostate_NN fibroblast_NN
          cell_NN line_NN from_IN a_DT normal_JJ male_JJ (_( analyzed_VBD twice_RB )_) ,_, abdominal_NN
          skin_NN fibroblasts_NNS from_IN a_DT normal_JJ male_NN ,_, forearm_NN fibroblasts_NNS
          from_IN a_DT normal_JJ male_NN ,_, and_CC genital_JJ fibroblasts_NNS from_IN two_CD AIS_NNP
          46_CD ,_, XY_NNP females_NNS who_WP had_VBD documented_VBN AR_NNP mosaicism_NN (_( ARD_NNP 364_CD ,_,
          ARD_NNP 465_CD ,_, Table_NNP 1_LS )_) ._. The_DT ARD_NNP 364_CD and_CC ARD_NNP 465_CD lines_NNS express_VBP
          wild-type_JJ AR_NNP and_CC were_VBD derived_VBN from_IN individuals_NNS who_WP were_VBD
          mosaics_NNS for_IN wild-type_JJ AR_NNP and_CC AR_NNP with_IN a_DT premature_JJ stop_NN
          codon_NN [_NN 7_CD ]_NN ._. Hierarchical_NNP cluster_NN analysis_NN ,_, based_VBN on_IN the_DT
          expression_NN of_IN 472_CD of_IN the_DT 487_CD previously_RB identified_VBN
          transcripts_NNS with_IN measurable_JJ expression_NN across_IN at_IN least_JJS
          80_CD %_NN of_IN 24_CD experiments_NNS ,_, separated_JJ the_DT fibroblasts_NNS into_IN
          those_DT with_IN gene-expression_JJ patterns_NNS resembling_VBG normal_JJ
          male_JJ foreskin_NN fibroblasts_NNS and_CC a_DT second_JJ group_NN with_IN an_DT
          expression_NN pattern_NN more_RBR similar_JJ to_TO labial_NN skin_NN
          fibroblasts_NNS from_IN AIS-affected_NNP individuals_NNS (_( Figure_NN 2_LS )_) ._. The_DT
          latter_JJ group_NN contained_VBD all_DT five_CD gonadal_NN fibroblast_NN lines_NNS
          from_IN complete_JJ AIS_NNP females_NNS as_RB well_RB as_IN the_DT fibroblast_NN lines_NNS
          from_IN abdominal_NN and_CC forearm_NN skin_NN ._. The_DT prostate_NN
          fibroblasts_NNS ,_, on_IN the_DT other_JJ hand_NN ,_, displayed_VBN expression_NN
          patterns_NNS largely_RB similar_JJ to_TO the_DT normal_JJ male_JJ foreskin_NN
          cells_NNS ._. Notably_RB ,_, the_DT two_CD mosaic_JJ AIS_NNP cell_NN lines_NNS ARD_NNP 364_CD and_CC
          ARD_NNP 465_CD showed_VBD gene-expression_JJ patterns_NNS that_IN most_JJS
          resembled_JJ normal_JJ male_JJ foreskin_NN (_( Figure_NN 2_LS )_) ._.
          Comparison_NNP of_IN expression_NN patterns_NNS in_IN genital_JJ
          fibroblasts_NNS from_IN normal_JJ and_CC AIS-affected_NNP individuals_NNS ,_, and_CC
          fibroblasts_NNS from_IN extragenital_NN sites_NNS ,_, offers_VBZ possible_JJ
          insights_NNS into_IN the_DT programs_NNS that_WDT underlie_VB genital_JJ
          development_NN ._. For_IN instance_NN ,_, transcripts_NNS encoding_VBG homeobox_NN
          A_DT 13_CD protein_NN (_( HOXA_NNP 13_CD )_) and_CC T-_NNP box_NN proteins_NNS (_( TBX_NNP )_) showed_VBD
          striking_JJ differences_NNS in_IN their_PRP$ expression_NN levels_NNS between_IN
          the_NNP '_POS male_JJ genital_JJ '_POS and_CC '_POS AIS_NNP /_NN extragenital_NN '_'' fibroblasts_NNS ._. 
          HOXA_NNP 13_CD was_VBD expressed_VBN at_IN high_JJ levels_NNS
          in_IN normal_JJ male_JJ foreskin_NN fibroblasts_NNS and_CC at_IN low_JJ levels_NNS in_IN
          all_DT AIS_NNP and_CC extragenital_NN fibroblasts_NNS (_( Figure_NN 2_LS )_) ._. T-_NNP box_NN
          gene_NN 3_CD (_( 
          TBX_NNP 3_LS )_) was_VBD expressed_VBN at_IN higher_JJR
          levels_NNS in_IN the_DT fibroblasts_NNS from_IN genital_JJ skin_NN ,_, extragenital_NN
          skin_NN or_CC prostate_NN from_IN males_NNS than_IN in_IN genital_JJ skin_NN
          fibroblasts_NNS from_IN AIS_NNP 46_CD ,_, XY_NNP females_NNS (_( Figure_NN 2_LS )_) ._. 
          TBX_NNP 2_CD showed_VBD an_DT almost_RB identical_JJ
          expression_NN profile_NN to_TO 
          TBX_NNP 3_CD ,_, whereas_IN high_JJ 
          TBX_NNP 5_CD expression_NN appeared_VBD to_TO be_VB
          restricted_VBN to_TO foreskin_NN fibroblasts_NNS from_IN normal_JJ males_NNS
          (_( including_VBG those_DT from_IN the_DT phenotypically_RB female_JJ mosaic_JJ
          patient_NN ARD_NNP 364_CD )_) ._. 
          BMP_NN 4_CD (_( bone_NN morphogenetic_JJ protein_NN 4_LS )_)
          was_VBD predominantly_RB expressed_VBN in_IN foreskin_NN fibroblasts_NNS from_IN
          normal_JJ males_NNS and_CC in_IN prostate_NN fibroblasts_NNS (_( Figure_NN 2_LS )_) ._. 
          WNT_NNP 2_CD (_( wingless-type_JJ MMTV_NNP
          integration_NN site_NN family_NN member_NN 2_LS )_) was_VBD part_NN of_IN a_DT small_JJ
          gene_NN cluster_NN with_IN high_JJ expression_NN in_IN normal_JJ male_JJ foreskin_NN
          fibroblasts_NNS that_WDT distinguished_VBD these_DT samples_NNS from_IN all_DT
          other_JJ fibroblasts_NNS (_( Figure_NN 2_LS )_) ._.
          Compared_VBN to_TO genital_JJ and_CC gonadal_NN fibroblasts_NNS from_IN 46_CD ,_, XY_NNP
          females_NNS ,_, fibroblasts_NNS from_IN normal_JJ male_JJ genital_JJ tissues_NNS
          showed_VBD pronounced_VBN differences_NNS in_IN expression_NN of_IN cell_NN
          adhesion_NN and_CC extracellular_NN matrix_NN genes_NNS ._. For_IN example_NN ,_,
          cadherin_NN 13_CD (_( 
          CDH_NNP 13_CD )_) ,_, versican_NN (_( 
          CSPG_NNP 2_LS )_) ,_, collagen_NN 8_CD A_DT 1_CD (_( 
          COL_NNP 8_CD A_DT 1_LS )_) ,_, collagen_NN 12_CD A_DT 1_CD (_( 
          COL_NNP 12_CD A_DT 1_LS )_) ,_, 
          P_NN 4_CD HA_NNP 2_CD (_( encoding_VBG a_DT
          procollagen-modifying_JJ enzyme_NN )_) all_DT showed_VBD relatively_RB low_JJ
          expression_NN in_IN the_DT genital_JJ skin_NN fibroblasts_NNS of_IN normal_JJ
          males_NNS ,_, whereas_IN tenascin_NN XB_NNP (_( 
          TNXB_NNP )_) ,_, nidogen_NN 2_CD (_( 
          NID_NNP 2_LS )_) ,_, laminins_NNS (_( 
          LAMA_NNP 3_CD ,_, 
          LAMA_NNP 4_LS )_) and_CC tissue_NN inhibitor_NN of_IN
          metalloproteinase_NN 1_CD (_( 
          TIMP_NNP 1_LS )_) all_DT showed_VBD relatively_RB high_JJ
          expression_NN levels_NNS compared_VBN to_TO AIS-derived_NNP fibroblasts_NNS
          (_( Figure_NN 2_LS )_) ._. Several_JJ of_IN the_DT differentially_RB expressed_VBN
          genes_NNS ,_, including_VBG aldo-keto_JJ reductase_NN 1_CD C_NNP 1_CD (_( 
          AKR_NNP 1_CD C_NNP 1_LS )_) ,_, aldehyde_NN dehydrogenase_NN
          1_CD A_DT 1_CD (_( 
          ALDH_NNP 1_CD A_DT 1_LS )_) ,_, and_CC alcohol_NN
          dehydrogenase_NN 1_CD B_NNP (_( 
          ADH_NNP 1_CD B_NNP )_) ,_, function_NN in_IN sex_NN steroid_NN
          and_CC retinoic_JJ acid_NN metabolism_NN (_( Figure_NN 2_LS )_) ._. Other_JJ
          differentially_RB expressed_VBD genes_NNS ,_, such_JJ as_IN mitogen-activated_JJ
          protein_NN kinase_NN 14_CD (_( 
          MAP_NNP 3_CD K_NNP 14_CD )_) ,_, and_CC STAT-induced_NNP STAT_NNP
          inhibitors_NNS 2_CD and_CC 3_CD (_( 
          STATI_NNP 2_CD ,_, 
          SSI-_NNP 3_LS )_) ,_, encode_NN proteins_NNS involved_VBN
          in_IN intracellular_NN signal_NN transduction_NN ._.
        
        
          Transcriptional_NNP response_NN of_IN cultured_JJ genital_JJ
          fibroblasts_NNS to_TO androgen_NN treatment_NN
          We_PRP tested_VBD the_DT responses_NNS of_IN normal_JJ and_CC AIS_NNP genital_JJ
          fibroblasts_NNS to_TO dihydrotestosterone_NN (_( DHT_NNP )_) ,_, under_IN culture_NN
          conditions_NNS similar_JJ to_TO those_DT that_WDT were_VBD reported_VBN to_TO produce_VB
          aromatase_NN induction_NN in_IN these_DT cells_NNS [_NN 8_CD ]_NN ._. Cells_NNP were_VBD
          treated_VBN with_IN DHT_NNP (_( 100_CD -_: 1_CD ,_, 000_CD nM_NN )_) both_DT at_IN confluency_NN (_( G_NNP 
          0_CD )_) and_CC during_IN exponential_NN growth_NN ,_, and_CC
          transcript_NN levels_NNS were_VBD assessed_VBN using_VBG DNA_NNP microarrays_NNS ._.
          Unsupervised_NNP hierarchical_JJ clustering_VBG did_VBD not_RB disclose_VB any_DT
          obvious_JJ differences_NNS in_IN gene-expression_JJ patterns_NNS between_IN
          DHT-treated_NNP and_CC ethanol-treated_JJ fibroblasts_NNS ,_, either_CC in_IN
          normal_JJ controls_NNS or_CC in_IN AIS-derived_NNP cell_NN lines_NNS ._. We_PRP treated_VBD
          LNCaP_NNP prostate_NN cancer_NN cells_NNS with_IN androgen_NN under_IN similar_JJ
          conditions_NNS and_CC readily_RB identified_VBN nearly_RB 500_CD transcripts_NNS
          modulated_JJ by_IN androgen_NN with_IN unsupervised_JJ hierarchical_JJ
          clustering_VBG analysis_NN and_CC with_IN supervised_JJ methods_NNS (_( [_NN 9_CD ]_NN
          and_CC data_NNS not_RB shown_VBN )_) ._. A_DT supervised_JJ analysis_NN comparing_VBG
          gene-expression_JJ patterns_NNS of_IN DHT-treated_NNP fibroblasts_NNS to_TO
          ethanol-treated_JJ controls_NNS was_VBD carried_VBN out_IN using_VBG the_DT SAM_NNP
          procedure_NN ._. Again_RB ,_, no_DT genes_NNS could_MD be_VB identified_VBN that_WDT were_VBD
          significantly_RB induced_VBN or_CC repressed_VBN by_IN DHT_NNP treatment_NN ._.
          Additional_JJ experiments_NNS using_VBG physiological_JJ concentrations_NNS
          of_IN androgen_NN (_( for_IN example_NN ,_, 0_CD ._. 01_CD -_: 1_CD nM_NN methyltrienolone_NN )_)
          also_RB failed_VBD to_TO disclose_VB any_DT androgen-responsive_JJ genes_NNS
          (_( data_NNS not_RB shown_VBN )_) ._. In_IN contrast_NN ,_, SAM_NNP analysis_NN identified_VBD
          1_CD ,_, 664_CD transcripts_NNS that_WDT differed_VBD significantly_RB between_IN
          proliferating_VBG and_CC confluent_NN cells_NNS ,_, and_CC 1_CD ,_, 232_CD transcripts_NNS
          that_WDT differed_VBD between_IN fibroblasts_NNS derived_VBN from_IN
          AIS-affected_NNP individuals_NNS and_CC normal_JJ male_JJ foreskin_NN ._.
          Hierarchical_NNP cluster_NN analysis_NN of_IN these_DT experiments_NNS
          clearly_RB showed_VBD the_DT distinct_JJ differences_NNS in_IN
          transcriptional_NN profiles_NNS between_IN AIS-derived_NNP and_CC normal_JJ
          male_JJ fibroblasts_NNS and_CC between_IN proliferating_VBG and_CC normal_JJ
          fibroblasts_NNS (_( Figure_NN 3_LS )_) ._. Cells_NNP derived_VBD from_IN the_DT same_JJ
          individual_JJ and_CC cultured_JJ under_IN the_DT same_JJ conditions_NNS always_RB
          showed_VBD highly_RB similar_JJ gene-expression_JJ patterns_NNS ,_,
          suggesting_VBG that_IN the_DT differences_NNS in_IN expression_NN between_IN
          individuals_NNS are_VBP stable_JJ and_CC reproducible_JJ despite_IN passage_NN 
          in_IN vitro_NN (_( Figure_NN 3_LS )_) ._.
        
      
      
        Discussion_NNP
        We_PRP found_VBD consistent_JJ ,_, characteristic_JJ differences_NNS in_IN
        baseline_NN gene_NN expression_NN patterns_NNS between_IN genital_JJ skin_NN
        fibroblasts_NNS from_IN normal_JJ males_NNS and_CC 46_CD ,_, XY_NNP female_JJ patients_NNS
        with_IN AIS_NNP ._. Many_JJ of_IN these_DT differences_NNS between_IN normal_JJ and_CC
        AIS-derived_NNP fibroblasts_NNS were_VBD also_RB observed_VBN in_IN gonadal_NN
        fibroblasts_NNS ,_, suggesting_VBG that_IN these_DT differences_NNS are_VBP not_RB
        purely_RB due_JJ to_TO differences_NNS in_IN the_DT anatomical_JJ site_NN of_IN origin_NN
        of_IN the_DT fibroblasts_NNS ._. Interestingly_RB ,_, fibroblasts_NNS derived_VBN from_IN
        abdominal_NN and_CC forearm_NN skin_NN ,_, regions_NNS with_IN relatively_RB little_RB
        sexual_JJ dimorphism_NN ,_, showed_VBD gene-expression_JJ patterns_NNS similar_JJ
        to_TO the_DT labial_NN skin_NN fibroblasts_NNS of_IN AIS_NNP patients_NNS ._. Together_RB ,_,
        these_DT data_NNS suggest_VBP that_IN the_DT AR_NNP is_VBZ involved_VBN in_IN determining_VBG a_DT
        stable_JJ and_CC stereotypical_JJ program_NN of_IN gene_NN expression_NN in_IN
        genital_JJ fibroblasts_NNS that_WDT does_VBZ not_RB require_VB the_DT continuing_VBG
        presence_NN of_IN androgen_NN for_IN its_PRP$ maintenance_NN ._.
        A_DT critical_JJ question_NN raised_VBN by_IN these_DT results_NNS is_VBZ whether_IN
        the_DT observed_VBN differences_NNS between_IN genital_JJ fibroblasts_NNS from_IN
        males_NNS and_CC AIS_NNP females_NNS reflect_VBP cell-autonomous_JJ effects_NNS of_IN
        androgen_NN exposure_NN during_IN development_NN ,_, or_CC indirect_JJ effects_NNS
        of_IN the_DT AR-dependent_NNP genital_JJ morphogenetic_JJ program_NN ._. One_CD
        possible_JJ interpretation_NN of_IN these_DT data_NNS is_VBZ that_IN the_DT distinct_JJ
        patterns_NNS of_IN expression_NN could_MD have_VB been_VBN due_JJ to_TO differences_NNS
        in_IN the_DT origin_NN or_CC the_DT developmental_NN milieu_NN of_IN foreskin_NN
        fibroblasts_NNS ,_, derived_VBN from_IN the_DT genital_JJ tubercle_NN ,_, as_IN opposed_VBN
        to_TO the_DT labial_NN fibroblasts_NNS ,_, derived_VBN from_IN the_DT genital_JJ
        swellings_NNS [_NN 10_CD ]_NN ._. The_DT differences_NNS in_IN gene_NN expression_NN we_PRP
        observed_VBD in_IN AIS_NNP fibroblasts_NNS of_IN gonadal_NN origin_NN compared_VBN to_TO
        those_DT of_IN labial_NN origin_NN support_NN this_DT view_NN (_( Figure_NN 3_LS )_) ._. We_PRP
        have_VBP observed_VBN consistent_JJ and_CC characteristic_JJ differences_NNS in_IN
        the_DT gene-expression_JJ patterns_NNS of_IN skin_NN fibroblasts_NNS derived_VBN
        from_IN different_JJ locations_NNS on_IN the_DT body_NN [_NN 11_CD ]_NN ._. However_RB ,_, the_DT
        current_JJ set_NN of_IN experiments_NNS suggests_VBZ that_IN the_DT androgen_NN
        receptor_NN has_VBZ a_DT cell-autonomous_JJ role_NN which_WDT contributes_VBZ to_TO a_DT
        stable_JJ androgen-independent_JJ gene-expression_JJ pattern_NN in_IN
        genital_JJ fibroblasts_NNS ._. Expression_NNP patterns_NNS in_IN cultured_JJ labial_NN
        skin_NN fibroblasts_NNS derived_VBN from_IN two_CD different_JJ individuals_NNS
        with_IN AR_NNP mosaicism_NN suggested_VBD that_IN the_DT cell-autonomous_JJ AR_NNP
        status_NN was_VBD a_DT relevant_JJ determinant_NN of_IN baseline_NN gene_NN
        expression_NN in_IN genital_JJ skin_NN fibroblasts_NNS ._. Both_DT these_DT
        fibroblast_NN lines_NNS ,_, although_IN derived_VBN from_IN morphologically_RB
        female_JJ genitalia_NN in_IN phenotypically_RB female_JJ 46_CD ,_, XY_NNP individuals_NNS
        mosaic_JJ for_IN AR-inactivating_NNP mutations_NNS ,_, expressed_VBD wild-type_JJ
        AR_NNP in_IN the_DT cultured_JJ cells_NNS ._. These_DT female_JJ AIS-affected_NNP
        individuals_NNS are_VBP thought_VBN to_TO have_VB acquired_VBN their_PRP$ 
        AR_NNP gene_NN mutations_NNS post-zygotically_JJ [_NN
        12_CD ]_NN ._. ARD_NNP 364_CD ,_, which_WDT showed_VBD AR_NNP protein_NN expression_NN and_CC
        binding_VBG in_IN the_DT range_NN of_IN normal_JJ male_JJ foreskin_NN fibroblasts_NNS (_(
        [_NN 7_CD ]_NN and_CC see_VB Table_NNP 1_LS )_) ,_, despite_IN its_PRP$ origin_NN from_IN
        anatomically_RB female_JJ genitalia_NN ,_, had_VBD a_DT gene-expression_JJ
        pattern_NN indistinguishable_JJ from_IN foreskin_NN fibroblasts_NNS of_IN
        normal_JJ males_NNS (_( Figure_NN 2_LS )_) ._. The_DT second_JJ fibroblast_NN line_NN from_IN an_DT
        AR_NNP mosaic_JJ patient_NN ,_, ARD_NNP 465_CD (_( Table_NNP 1_LS )_) ,_, had_VBD very_RB low_JJ wild-type_JJ
        AR_NNP expression_NN and_CC showed_VBD baseline_NN gene-expression_JJ patterns_NNS
        that_WDT were_VBD nevertheless_RB more_RBR similar_JJ to_TO normal_JJ male_JJ foreskin_NN
        and_CC prostate_NN fibroblasts_NNS than_IN to_TO any_DT of_IN the_DT AIS-derived_NNP
        cell_NN lines_NNS (_( Figure_NN 2_LS )_) ._.
        The_DT discrepancy_NN between_IN the_DT female_JJ phenotype_NN of_IN these_DT
        mosaic_JJ individuals_NNS despite_IN expression_NN of_IN the_DT wild-type_JJ AR_NNP
        in_IN cultured_JJ genital_JJ skin_NN fibroblasts_NNS is_VBZ not_RB resolved_VBN to_TO
        date_NN [_NN 7_CD ]_NN ._. It_PRP may_MD be_VB explained_VBN by_IN a_DT time-dependent_JJ rise_NN
        of_IN an_DT originally_RB small_JJ fraction_NN of_IN cells_NNS containing_VBG the_DT
        wild-type_JJ 
        AR_NNP allele_NN in_IN the_DT mosaic_JJ genital_JJ
        mesenchyme_NN during_IN prenatal_NN and_CC postnatal_NN development_NN ,_, or_CC by_IN
        differences_NNS between_IN 
        in_IN vivo_NN and_CC 
        in_IN vitro_NN conditions_NNS ._. Yet_RB ,_, the_DT
        documented_VBN expression_NN of_IN the_DT wild-type_JJ AR_NNP in_IN cultures_NNS of_IN
        these_DT labial_NN cells_NNS supports_VBZ the_DT idea_NN that_IN the_DT AR_NNP status_NN of_IN
        the_DT fibroblast_NN was_VBD an_DT important_JJ intrinsic_JJ determinant_NN of_IN
        the_DT basal_NN transcription_NN patterns_NNS we_PRP identified_VBD ._. Therefore_RB ,_,
        the_DT AR_NNP appears_VBZ to_TO be_VB involved_VBN in_IN setting_VBG long-lasting_JJ
        gene-expression_JJ patterns_NNS in_IN genital_JJ skin_NN fibroblasts_NNS ._.
        Comparison_NNP of_IN gene-expression_JJ patterns_NNS in_IN genital_JJ
        fibroblasts_NNS from_IN normal_JJ and_CC AIS-affected_NNP individuals_NNS ,_, and_CC
        in_IN fibroblasts_NNS from_IN extragenital_NN sites_NNS ,_, may_MD offer_VB clues_NNS to_TO
        the_DT programs_NNS that_WDT underlie_VB external_JJ genital_JJ development_NN ._.
        Both_DT cell_NN adhesion_NN and_CC connective_JJ tissue_NN remodeling_VBG are_VBP
        indispensable_JJ for_IN normal_JJ development_NN and_CC maintenance_NN of_IN
        tissue_NN integrity_NN [_NN 13_CD 14_CD 15_CD ]_NN ._. The_DT differential_NN expression_NN
        of_IN proteoglycans_NNS ,_, collagens_NNS and_CC cell_NN adhesion_NN molecules_NNS
        (_( for_IN example_NN cadherin_NN 13_CD )_) might_MD be_VB involved_VBN in_IN genital_JJ
        morphogenesis_NNS and_CC later_RB stability_NN of_IN sexually_RB dimorphic_JJ
        traits_NNS of_IN the_DT external_JJ genitalia_NN ._. Some_DT genes_NNS expressed_VBD in_IN
        wild-type_JJ AR_NNP cells_NNS could_MD influence_VB androgen_NN signaling_VBG ._. For_IN
        instance_NN ,_, aldo-keto_JJ reductase_NN 1_CD C_NNP 1_CD is_VBZ specifically_RB involved_VBN
        in_IN cellular_JJ androgen_NN metabolism_NN [_NN 16_CD ]_NN and_CC thus_RB may_MD
        modulate_VBP the_DT spectrum_NN of_IN cellular_JJ androgenic_JJ steroids_NNS
        available_JJ for_IN activation_NN of_IN the_DT AR_NNP ._. Structurally_NNP different_JJ
        androgens_NNS elicit_NN different_JJ patterns_NNS of_IN response_NN from_IN
        several_JJ androgen-responsive_JJ promoters_NNS ,_, suggesting_VBG that_IN the_DT
        type_NN of_IN ligand_NN present_NN could_MD affect_VB cellular_JJ response_NN [_NN 17_CD
        ]_NN ._. Mitogen-activated_NNP protein_NN kinase_NN 14_CD ,_, and_CC STAT-induced_NNP
        STAT_NNP inhibitors_NNS 2_CD and_CC 3_CD were_VBD expressed_VBN at_IN significantly_RB
        higher_JJR levels_NNS in_IN cells_NNS with_IN wild-type_JJ AR_NNP ._. Both_DT MAP_NNP kinase_NN
        and_CC STAT_NNP pathways_NNS are_VBP involved_VBN in_IN AR-dependent_NNP regulation_NN
        and_CC in_IN ligand-independent_JJ activation_NN of_IN the_DT AR_NNP [_NN 18_CD ]_NN ._.
        Differential_NNP expression_NN of_IN aldehyde_NN dehydrogenase_NN 1_CD A_DT 1_CD and_CC
        alcohol_NN dehydrogenase_NN 1_CD B_NNP ,_, enzymes_NNS that_WDT affect_VBP retinoic_JJ acid_NN
        biosynthesis_NNS ,_, suggest_VBP that_IN other_JJ signaling_VBG pathways_NNS may_MD
        participate_VB in_IN the_DT AR-initiated_NNP programs_NNS of_IN external_JJ
        genital_JJ differentiation_NN [_NN 19_CD 20_CD ]_NN ._.
        Several_JJ genes_NNS expressed_VBD specifically_RB in_IN the_DT normal_JJ male_JJ
        foreskin_NN fibroblasts_NNS have_VBP been_VBN previously_RB implicated_VBN in_IN
        male_JJ genital_JJ development_NN ,_, including_VBG 
        HOXA_NNP 13_CD ,_, the_DT T-_NNP box_NN genes_NNS ,_, 
        BMP_NN 4_CD and_CC 
        DWnt_NNP 2_CD ._. Mutations_NNP in_IN 
        HOXA_NNP 13_CD can_MD cause_VB distal_NN limb_NN and_CC
        urogenital-tract_JJ malformations_NNS such_JJ as_IN male_JJ hypospadias_NNS in_IN
        hand-foot-genital_JJ syndrome_NN [_NN 21_CD ]_NN ._. T-_NNP box_NN genes_NNS (_( 
        TBX_NNP )_) are_VBP essential_JJ early_JJ regulators_NNS
        of_IN limb_NN development_NN and_CC also_RB appear_VB to_TO be_VB involved_VBN in_IN male_JJ
        genital_JJ development_NN [_NN 22_CD 23_CD ]_NN ._. Mutations_NNP in_IN 
        TBX_NNP 3_CD cause_VB the_DT ulnar-mammary_JJ syndrome_NN
        characterized_VBN by_IN limb_NN ,_, apocrine_NN ,_, and_CC genital_JJ developmental_NN
        abnormalities_NNS [_NN 23_CD ]_NN ._. Expression_NNP of_IN T-_NNP box_NN genes_NNS 2_CD ,_, 3_CD ,_, and_CC
        5_CD was_VBD significantly_RB higher_JJR in_IN normal_JJ male_JJ foreskin_NN
        fibroblasts_NNS than_IN in_IN AIS_NNP genital_JJ fibroblasts_NNS ._. 
        BMP_NN 4_CD has_VBZ been_VBN implicated_VBN in_IN ductal_NN
        budding_VBG and_CC branching_VBG during_IN prostate_NN development_NN [_NN 24_CD ]_NN
        and_CC a_DT potential_JJ role_NN of_IN BMP_NN 4_CD in_IN external_JJ genital_JJ
        development_NN has_VBZ also_RB been_VBN postulated_JJ [_NN 25_CD ]_NN ._. 
        DWnt_NNP 2_CD has_VBZ been_VBN found_VBN to_TO have_VB roles_NNS in_IN
        sex-specific_JJ cell_NN determination_NN in_IN the_DT gonads_NNS and_CC genital_JJ
        disc_NN of_IN 
        Drosophila_NNP [_NN 26_CD ]_NN ._. Thus_RB ,_, mutations_NNS
        in_IN genes_NNS characteristically_RB expressed_VBD in_IN normal_JJ male_JJ
        foreskin_NN fibroblasts_NNS can_MD ,_, in_IN some_DT cases_NNS ,_, lead_VB to_TO defective_JJ
        genital_JJ development_NN ._. The_DT data_NNS from_IN these_DT experiments_NNS
        therefore_RB provide_VBP candidate_NN genes_NNS for_IN further_JJ investigation_NN
        in_IN patients_NNS with_IN genital_JJ malformations_NNS ._.
        As_IN normal_JJ genital_JJ skin_NN fibroblasts_NNS of_IN 46_CD ,_, XY_NNP male_JJ
        individuals_NNS express_VBP the_DT AR_NNP 
        in_IN vitro_NN (_( see_VB Table_NNP 1_CD and_CC [_NN 4_CD 7_CD ]_NN )_) ,_,
        we_PRP had_VBD anticipated_VBN that_DT androgen_NN treatment_NN would_MD elicit_NN a_DT
        transcriptional_NN response_NN program_NN that_WDT could_MD provide_VB
        additional_JJ insights_NNS into_IN the_DT role_NN of_IN androgen_NN in_IN genital_JJ
        development_NN ._. We_PRP have_VBP previously_RB used_VBN a_DT similar_JJ approach_NN to_TO
        delineate_NN the_DT transcriptional_NN programs_NNS activated_VBN in_IN
        prostate_NN cancer_NN cells_NNS in_IN response_NN to_TO androgen_NN [_NN 9_CD ]_NN ._. We_PRP
        had_VBD hoped_VBN that_DT comparison_NN of_IN transcriptional_NN responses_NNS of_IN
        normal_JJ fibroblasts_NNS to_TO those_DT from_IN AIS-affected_NNP individuals_NNS
        with_IN varying_VBG degrees_NNS of_IN genital_JJ ambiguity_NN would_MD provide_VB
        still_RB further_JJ insights_NNS into_IN androgen_NN 's_POS role_NN in_IN genital_JJ
        morphogenesis_NNS ._. However_RB ,_, we_PRP were_VBD unable_JJ to_TO detect_VB any_DT
        significant_JJ changes_NNS in_IN gene-expression_JJ patterns_NNS in_IN
        cultured_JJ ,_, AR-expressing_NNP genital_JJ fibroblasts_NNS or_CC in_IN
        AIS-derived_NNP fibroblasts_NNS in_IN response_NN to_TO androgens_NNS ._. Although_IN
        two_CD previous_JJ reports_NNS have_VBP shown_VBN increases_NNS in_IN aromatase_NN
        enzymatic_JJ activity_NN in_IN genital_JJ skin_NN fibroblasts_NNS treated_VBN with_IN
        dihydrotestosterone_NN (_( DHT_NNP )_) [_NN 8_CD 27_CD ]_NN ,_, others_NNS have_VBP failed_VBN to_TO
        observe_VB changes_NNS in_IN aromatase_NN activity_NN in_IN response_NN to_TO
        androgen_NN [_NN 28_CD ]_NN ._. In_IN agreement_NN with_IN our_PRP$ findings_NNS ,_, Elmlinger_NNP
        
        et_CC al_NN ._. found_VBD significantly_RB different_JJ
        baseline_NN expression_NN levels_NNS of_IN insulin-like_JJ growth_NN factor_NN
        (_( IGF_NNP )_) and_CC insulin-like_JJ growth_NN factor_NN binding_JJ protein_NN
        (_( IGFBP_NNP )_) between_IN normal_JJ and_CC AIS-derived_NNP genital_JJ skin_NN
        fibroblasts_NNS ,_, and_CC could_MD not_RB detect_VB changes_NNS in_IN transcript_NN
        levels_NNS in_IN response_NN to_TO androgen_NN treatment_NN [_NN 29_CD ]_NN ._. In_IN normal_JJ
        genital_JJ fibroblasts_NNS ,_, androgen-responsive_JJ reporter_NN genes_NNS can_MD
        only_RB be_VB activated_VBN by_IN expression_NN of_IN co-transfected_JJ AR_NNP in_IN the_DT
        presence_NN of_IN ligand_NN [_NN 30_CD ]_NN ._. Therefore_RB ,_, endogenous_JJ AR_NNP
        expression_NN itself_PRP may_MD be_VB insufficient_JJ in_IN genital_JJ skin_NN
        fibroblasts_NNS to_TO elicit_NN a_DT transcriptional_NN response_NN ._. Moreover_RB ,_,
        the_DT lack_NN of_IN detectable_JJ changes_NNS in_IN transcript_NN levels_NNS for_IN any_DT
        of_IN the_DT 30_CD ,_, 000_CD genes_NNS in_IN the_DT AIS-fibroblasts_NNP virtually_RB
        excludes_VBZ the_DT possibility_NN that_IN DHT_NNP or_CC R_NN 1881_CD could_MD be_VB acting_VBG
        through_IN other_JJ steroid_NN receptors_NNS or_CC other_JJ signaling_VBG
        pathways_NNS ._.
        The_DT differences_NNS in_IN androgen_NN responsiveness_NNS we_PRP have_VBP
        observed_VBN between_IN normal_JJ genital_JJ fibroblasts_NNS and_CC prostate_NN
        cancer_NN epithelial_NN cells_NNS 
        in_IN vitro_NN might_MD reflect_VB the_DT responses_NNS
        seen_VBN 
        in_IN vivo_NN ._. Prostate_NNP epithelial_NN cells_NNS
        retain_VBP exquisite_JJ sensitivity_NN to_TO androgen_NN throughout_IN life_NN ._.
        Androgen_NNP deprivation_NN produces_VBZ profound_JJ involution_NN of_IN the_DT
        prostate_NN ,_, particularly_RB of_IN the_DT epithelial_NN component_NN ,_, but_CC
        little_JJ or_CC no_DT change_NN in_IN the_DT external_JJ genitalia_NN ._. It_PRP is_VBZ
        possible_JJ that_IN genital_JJ mesenchymal_NN cells_NNS are_VBP only_RB capable_JJ of_IN
        responding_VBG to_TO androgen_NN at_IN discrete_JJ stages_NNS in_IN development_NN in_IN
        their_PRP$ specific_JJ 
        in_IN vivo_NN environment_NN ._. In_IN mice_NNS ,_, stromal_NN
        androgen_NN responsiveness_NNS is_VBZ restricted_VBN to_TO the_DT earliest_JJS
        stages_NNS in_IN prostate_NN development_NN ,_, and_CC later_RB the_DT epithelial_NN
        compartment_NN becomes_VBZ responsive_JJ and_CC remains_VBZ so_RB [_NN 1_CD ]_NN ._. This_DT
        responsiveness_NNS may_MD be_VB mediated_JJ through_IN the_DT expression_NN of_IN
        specific_JJ AR_NNP co-regulators_JJ ._. Compared_VBN to_TO LNCaP_NNP cells_NNS ,_, normal_JJ
        male_JJ genital_JJ fibroblasts_NNS show_VBP distinctly_RB lower_JJR baseline_NN
        expression_NN of_IN several_JJ AR_NNP co-regulators_JJ (_( such_JJ as_IN NCOA_NNP 2_CD
        (_( GRIP-_NNP 1_LS )_) ,_, NCOA_NNP 3_CD (_( TRAM-_NNP 1_LS )_) ,_, ARA_NNP 54_CD (_( RNF_NNP 14_CD )_) ,_, data_NNS not_RB shown_VBN )_) ._.
        Thus_RB ,_, genital_JJ fibroblasts_NNS may_MD express_VB critical_JJ AR_NNP
        co-regulators_JJ at_IN discrete_JJ times_NNS during_IN development_NN that_WDT
        allow_VBP them_PRP to_TO respond_VB by_IN setting_VBG up_RP long-lasting_JJ
        transcriptional_NN programs_NNS that_WDT underlie_VB the_DT genesis_NN and_CC
        maintenance_NN of_IN genital_JJ morphology_NN ._.
      
      
        Conclusions_NNP
        Our_PRP$ data_NNS suggest_VBP that_IN in_IN addition_NN to_TO
        androgen-independent_JJ positional_JJ influences_NNS on_IN fibroblast_NN
        phenotypes_NNS ,_, the_DT AR_NNP is_VBZ originally_RB involved_VBN in_IN establishing_VBG
        stable_JJ and_CC reproducible_JJ patterns_NNS of_IN gene_NN expression_NN in_IN
        stromal_NN cells_NNS during_IN genital_JJ differentiation_NN ,_, which_WDT are_VBP
        reflected_VBN in_IN the_DT differences_NNS in_IN global_JJ gene-expression_JJ
        patterns_NNS between_IN fibroblasts_NNS cultured_JJ from_IN the_DT genital_JJ skin_NN
        of_IN normal_JJ individuals_NNS and_CC females_NNS affected_VBN by_IN AIS_NNP ._.
        Comparison_NNP of_IN the_DT expression_NN patterns_NNS of_IN genital_JJ
        fibroblasts_NNS from_IN 46_CD ,_, XY_NNP normal_JJ males_NNS and_CC 46_CD ,_, XY_NNP females_NNS with_IN
        inactivated_JJ AR_NNP provides_VBZ a_DT window_NN on_IN the_DT AR-dependent_NNP
        gene-expression_JJ programs_NNS within_IN the_DT urogenital_NN mesenchyme_NN ,_,
        which_WDT contribute_VBP to_TO the_DT development_NN and_CC structural_JJ
        integrity_NN of_IN male_JJ and_CC female_JJ genitalia_NN ._. For_IN further_JJ
        discrimination_NN of_IN androgen-independent_JJ positional_JJ effects_NNS
        from_IN prenatal_NN androgen_NN actions_NNS on_IN expression_NN phenotypes_NNS of_IN
        genital_JJ fibroblast_NN strains_NNS ,_, comparative_JJ expression_NN
        profiling_VBG of_IN homologous_RB genital_JJ tissues_NNS is_VBZ needed_VBN ._. The_DT
        apparent_JJ lack_NN of_IN response_NN of_IN genital_JJ fibroblasts_NNS to_TO
        androgen_NN 
        in_IN vitro_NN ,_, despite_IN expression_NN of_IN a_DT
        normal_JJ AR_NNP ,_, has_VBZ important_JJ implications_NNS for_IN future_JJ research_NN
        in_IN defining_VBG the_DT role_NN of_IN androgen_NN in_IN genital_JJ development_NN and_CC
        the_DT pathogenesis_NNS of_IN ambiguous_JJ genitalia_NN ._. Transcriptional_NNP
        profiling_VBG of_IN the_DT early_JJ stages_NNS of_IN genital_JJ development_NN 
        in_IN vivo_NN in_IN the_DT presence_NN and_CC absence_NN
        of_IN androgen_NN may_MD provide_VB further_JJ insights_NNS into_IN the_DT role_NN of_IN
        androgen_NN in_IN genital_JJ development_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP strains_NNS
          Primary_JJ cultures_NNS of_IN genital_JJ fibroblasts_NNS were_VBD
          established_VBN from_IN genital_JJ skin_NN biopsies_NNS (_( labia_NN majora_NN )_) or_CC
          gonadal_NN biopsies_NNS in_IN female_JJ AIS_NNP patients_NNS and_CC from_IN the_DT
          foreskin_NN of_IN normal_JJ males_NNS undergoing_VBG circumcision_NN ._.
          Abdominal_NNP skin_NN fibroblasts_NNS were_VBD derived_VBN from_IN the_DT midline_NN
          above_IN the_DT mons_NNS pubis_NNS of_IN a_DT fertile_JJ male_NN during_IN abdominal_NN
          surgery_NN ._. Forearm_NNP skin_NN fibroblasts_NNS from_IN a_DT normal_JJ male_NN were_VBD
          a_DT gift_NN from_IN H_NNP ._. Chang_NNP (_( Department_NNP of_IN Biochemistry_NNP ,_,
          Stanford_NNP University_NNP )_) ._. Peripheral_NNP zone_NN prostate_NN
          fibroblasts_NNS were_VBD a_DT gift_NN from_IN D_NNP ._. Peehl_NNP (_( Department_NNP of_IN
          Urology_NNP ,_, Stanford_NNP University_NNP )_) and_CC were_VBD established_VBN from_IN a_DT
          histologically_RB normal_JJ region_NN of_IN a_DT patient_NN undergoing_VBG
          prostatectomy_NN for_IN prostate_NN cancer_NN who_WP had_VBD not_RB been_VBN
          previously_RB treated_VBN with_IN hormonal_NN therapy_NN ._. Hormone-binding_NNP
          assays_NNS using_VBG methyltrienolone_NN (_( R_NN 1881_CD ,_,
          17_CD β-hydroxy-_JJ 17_CD α-methyl-_JJ 4_CD ,_, 9_CD ,_, 11_CD -_: estrotrien-_NN 3_CD -_: one_CD )_) and_CC
          androgen_NN receptor_NN sequencing_VBG have_VBP been_VBN described_VBN
          previously_RB [_NN 7_CD ]_NN ._.
        
        
          Cell_NNP culture_NN and_CC hormone_NN treatment_NN
          For_IN determination_NN of_IN basal_NN gene-expression_JJ profiles_NNS
          without_IN androgen_NN stimulation_NN ,_, fibroblasts_NNS were_VBD cultured_JJ
          on_IN 150_CD -_: mm_NN plastic_NN dishes_NNS at_IN 37_CD °_NN C_NNP with_IN 5_CD %_NN CO_NNP 
          2_CD ._. To_TO eliminate_VB possible_JJ artifacts_NNS
          due_JJ to_TO differing_VBG states_NNS of_IN proliferation_NN ,_, cells_NNS were_VBD
          grown_VBN to_TO confluence_NN ,_, at_IN which_WDT point_VBP they_PRP enter_VBP G_NNP 
          0_CD arrest_NN [_NN 31_CD ]_NN ._. They_PRP were_VBD maintained_VBN
          in_IN phenol-red-free_JJ DMEM_NNP F_NNP 12_CD (_( Dulbecco_NNP 's_POS modified_VBN Eagle_NNP
          Medium_NNP with_IN the_DT nutrient_NN mix_NN F_NN 12_CD ;_: Gibco_NNP )_) containing_VBG
          L-_NNP glutamine_NN ,_, 15_CD mM_NN Hepes_NNP buffer_NN ,_, penicillin_NN /_NN streptomycin_NN
          (_( Gibco_NNP )_) and_CC 12_CD ._. 9_CD %_NN of_IN a_DT constant_JJ lot_NN of_IN certified_VBN fetal_JJ
          calf_NN serum_NN (_( FCS_NNP ;_: Gibco_NNP )_) ._. The_DT pH_NN was_VBD adjusted_VBN to_TO 7_CD ._. 4_CD with_IN
          1_CD N_NNP NaOH_NNP and_CC the_DT medium_NN was_VBD exchanged_VBN every_DT 48_CD h_NN ._. At_IN day_NN
          13_CD the_DT last_JJ media_NNS exchange_NN was_VBD carried_VBN out_IN and_CC 96_CD h_NN later_RB
          cells_NNS were_VBD scraped_JJ and_CC mRNA_NN harvested_VBN directly_RB ._.
          Androgen_NNP stimulation_NN of_IN genital_JJ fibroblasts_NNS was_VBD
          carried_VBN out_IN under_IN two_CD different_JJ culture_NN conditions_NNS
          similar_JJ to_TO those_DT previously_RB reported_VBN to_TO produce_VB induction_NN
          of_IN aromatase_NN enzymatic_JJ activity_NN in_IN these_DT cell_NN lines_NNS [_NN 8_CD
          27_CD ]_NN ._. In_IN the_DT first_JJ ,_, cells_NNS were_VBD grown_VBN to_TO confluence_NN as_IN
          described_VBN above_IN using_VBG phenol-red-free_JJ DMEM_NNP F_NNP 12_CD containing_VBG
          L-_NNP glutamine_NN ,_, 15_CD mM_NN Hepes_NNP buffer_NN ,_, penicillin_NN /_NN streptomycin_NN
          (_( Gibco_NNP )_) with_IN 12_CD ._. 9_CD %_NN charcoal-stripped_JJ ,_, steroid-free_JJ FCS_NNP
          (_( D_NNP /_NN S-FCS_NNP )_) (_( Hyclone_NNP )_) to_TO ensure_VB androgen-depleted_JJ
          conditions_NNS in_IN control_NN cells_NNS ._. With_IN every_DT media_NNS exchange_VBP
          every_DT 48_CD h_NN ,_, cells_NNS received_VBD either_CC ethanol_NN in_IN a_DT final_JJ
          dilution_NN of_IN 1_CD :_: 100_CD ,_, 000_CD or_CC 100_CD nM_NN dihydrotestosterone_NN (_( DHT_NNP )_)
          dissolved_VBN in_IN ethanol_NN ._. The_DT last_JJ DHT_NNP treatment_NN was_VBD
          administered_VBN with_IN the_DT last_JJ media_NNS exchange_VBP 96_CD h_NN before_IN
          lysate_NN preparation_NN ._. In_IN total_JJ ,_, six_CD doses_NNS of_IN either_DT ethanol_NN
          or_CC 100_CD nM_NN DHT_NNP were_VBD given_VBN ._.
          In_IN the_DT second_RB set_NN of_IN experiments_NNS ,_, cells_NNS were_VBD cultured_JJ
          to_TO confluence_NN for_IN 14_CD days_NNS as_IN described_VBN above_IN ._. They_PRP were_VBD
          then_RB trypsinized_JJ and_CC seeded_VBN at_IN a_DT density_NN of_IN 3_CD ,_, 000_CD cells_NNS
          per_IN cm_NN 2_CD in_IN 150_CD -_: mm_NN plates_NNS ._. Twenty-four_CD hours_NNS later_RB ,_, medium_NN
          was_VBD removed_VBN ,_, and_CC cells_NNS were_VBD washed_VBN three_CD times_NNS with_IN new_JJ
          media_NNS containing_VBG 12_CD ._. 9_CD %_NN D_NNP /_NN S-FCS_NNP ,_, then_RB cultured_JJ for_IN another_DT
          24_CD -_: h_NN interval_NN in_IN the_DT absence_NN of_IN androgens_NNS ._. Cells_NNP were_VBD
          then_RB treated_VBN with_IN either_DT 1_CD :_: 100_CD ,_, 000_CD ethanol_NN ,_, 100_CD nM_NN or_CC
          1_CD ,_, 000_CD nM_NN DHT_NNP dissolved_VBN in_IN ethanol_NN ._. After_IN 24_CD h_NN incubation_NN ,_,
          exponentially_RB growing_VBG cells_NNS were_VBD harvested_VBN ._. LNCaP_NNP cells_NNS ,_,
          passaged_JJ and_CC treated_VBN under_IN similar_JJ conditions_NNS ,_, were_VBD used_VBN
          as_IN a_DT positive_JJ control_NN for_IN androgen_NN reponsiveness_NNS ._.
        
        
          RNA_NNP isolation_NN and_CC cDNA_NN labeling_VBG
          Protocols_NNP for_IN mRNA_NN preparation_NN and_CC cDNA_NN labeling_VBG are_VBP
          available_JJ online_NN [_NN 32_CD ]_NN ._. mRNA_NN (_( 2_CD μg_NN )_) from_IN single_JJ
          experiments_NNS was_VBD reverse_VB transcribed_JJ and_CC labeled_VBN with_IN Cy_NNP 5_CD
          (_( pseudo-coloured_JJ red_JJ )_) and_CC pooled_VBN reference_NN mRNA_NN was_VBD
          labeled_VBN with_IN Cy_NNP 3_CD (_( pseudo-coloured_JJ green_JJ )_) ._. Reference_NNP mRNA_NN
          contained_VBD equal_JJ mixtures_NNS of_IN fibroblast_NN mRNA_NN (_( pooled_VBN from_IN
          confluent_NN and_CC proliferating_VBG cultures_NNS of_IN normal_JJ and_CC AIS_NNP
          genital_JJ skin_NN fibroblasts_NNS )_) and_CC a_NNP '_POS common_JJ reference_NN '_'' of_IN
          mRNAs_NNS isolated_VBN from_IN 11_CD different_JJ proliferating_VBG cultured_JJ
          tumor_NN cell_NN lines_NNS that_IN we_PRP have_VBP described_VBN previously_RB [_NN 33_CD ]_NN
          ._.
        
        
          Microarrays_NNP and_CC hybridizations_NNS
          Microarrays_NNP with_IN approximately_RB 43_CD ,_, 000_CD
          sequence-validated_JJ PCR-amplified_NNP human_JJ cDNAs_NNS representing_VBG
          32_CD ,_, 968_CD UniGene_NNP clusters_NNS were_VBD manufactured_VBN as_IN described_VBN [_NN
          32_CD ]_NN ._. Hybridizations_NNP were_VBD performed_VBN using_VBG equal_JJ amounts_NNS
          of_IN Cy_NNP 3_CD -_: and_CC Cy_NNP 5_CD -_: labeled_VBN cDNAs_NNS according_VBG to_TO previously_RB
          published_VBN protocols_NNS [_NN 32_CD ]_NN ._. Hybridized_NNP microarrays_NNS were_VBD
          scanned_JJ using_VBG a_DT GenePix_NNP 4000_CD array_NN scanner_NN and_CC analyzed_VBD
          with_IN GenePix_NNP Pro_FW 3_CD ._. 0_CD software_NN (_( Axon_NNP Instruments_NNP ,_, Union_NNP
          City_NNP ,_, CA_NNP )_) ._.
        
        
          Microarray_NNP data_NNS analysis_NN
          Only_RB spots_VBZ with_IN fluorescence_NN signals_NNS 1_CD ._. 5_CD -_: fold_VB greater_JJR
          than_IN background_NN in_IN either_DT the_DT experimental_JJ or_CC reference_NN
          samples_NNS were_VBD included_VBN in_IN the_DT analysis_NN ._. To_TO correct_VB for_IN
          variations_NNS in_IN cDNA_NN labeling_VBG efficiency_NN ,_, we_PRP normalized_JJ the_DT
          Cy_NNP 5_CD /_NN Cy_NNP 3_CD fluorescence_NN ratios_NNS for_IN all_DT genes_NNS in_IN each_DT array_NN
          hybridization_NN to_TO obtain_VB an_DT average_JJ log_NN 
          2_CD (_( ratio_NN )_) of_IN 0_CD ._. We_PRP restricted_VBD our_PRP$
          analysis_NN to_TO genes_NNS with_IN measurable_JJ expression_NN in_IN 80_CD %_NN of_IN
          the_DT samples_NNS we_PRP analyzed_VBD ._. We_PRP used_VBD the_DT SAM_NNP procedure_NN [_NN 6_CD ]_NN
          to_TO identify_VB genes_NNS with_IN statistically_RB significant_JJ
          differences_NNS in_IN baseline_NN expression_NN levels_NNS between_IN normal_JJ
          and_CC AIS_NNP genital_JJ fibroblasts_NNS ._. The_DT SAM_NNP procedure_NN computes_VBZ a_DT
          two-sample_JJ T-_NNP statistic_NN (_( for_IN example_NN for_IN normal_JJ vs_NNS AIS_NNP
          cell_NN lines_NNS )_) for_IN the_DT normalized_JJ log_NN ratios_NNS of_IN
          gene-expression_JJ levels_NNS for_IN each_DT gene_NN ._. It_PRP thresholds_NNS the_DT
          T-_NNP statistics_NNS to_TO provide_VB a_DT '_POS significant_JJ '_POS gene_NN list_NN and_CC
          provides_VBZ an_DT estimate_NN of_IN the_DT false_JJ discovery_NN rate_NN (_( the_DT
          percent_NN of_IN genes_NNS identified_VBN by_IN chance_NN alone_RB )_) from_IN
          randomly_RB permuted_JJ data_NNS ._. Gene-expression_NNP data_NNS were_VBD
          clustered_VBN [_NN 34_CD 35_CD ]_NN and_CC results_NNS were_VBD visualized_JJ using_VBG
          TreeView_NNP software_NN [_NN 35_CD ]_NN ._.
          To_TO identify_VB the_DT effects_NNS of_IN androgen_NN treatment_NN on_IN gene_NN
          expression_NN in_IN genital_JJ fibroblasts_NNS ,_, we_PRP carried_VBD out_RP a_DT set_NN
          of_IN 21_CD DNA_NNP microarray_NN analyses_NNS of_IN mRNA_NN from_IN normal_JJ and_CC AIS_NNP
          genital_JJ fibroblasts_NNS ._. This_DT dataset_NN included_VBD cells_NNS treated_VBN
          at_IN confluence_NN (_( G_NNP 
          0_CD )_) or_CC during_IN exponential_NN
          proliferation_NN as_IN described_VBN above_IN ._. Raw_NNP data_NNS were_VBD filtered_VBN ,_,
          normalized_JJ and_CC centered_VBN as_IN described_VBN above_IN ._. We_PRP used_VBD the_DT
          SAM_NNP procedure_NN to_TO identify_VB transcripts_NNS with_IN significant_JJ
          differences_NNS in_IN expression_NN with_IN reference_NN to_TO the_DT origin_NN of_IN
          the_DT fibroblast_NN lines_NNS ,_, whether_IN the_DT cells_NNS were_VBD confluent_NN or_CC
          proliferating_VBG ,_, and_CC whether_IN they_PRP had_VBD been_VBN treated_VBN with_IN
          androgen_NN ._.
        
      
      
        Additional_JJ data_NNS files_NNS
        The_DT following_VBG files_NNS are_VBP available_JJ :_: a_DT figure_NN (_( Additional_JJ
        data_NNS file_VBP 1_LS )_) showing_VBG the_DT complete_JJ dataset_NN for_IN Figure_NN 1_CD ,_,
        with_IN associated_VBN array_NN tree_NN correlations_NNS (_( atr_NN )_) ,_, complete_JJ
        data_NNS table_NN (_( cdt_NN )_) and_CC gene_NN tree_NN correlations_NNS (_( gtr_NN )_) files_NNS
        (_( Additional_JJ data_NNS files_NNS 2_CD ,_, 3_CD and_CC 4_LS )_) ;_: a_DT figure_NN (_( Additional_JJ
        data_NNS file_VBP 5_LS )_) showing_VBG the_DT complete_JJ dataset_NN for_IN Figure_NN 2_CD ,_,
        with_IN associated_VBN atr_NN ,_, cdt_NN and_CC gtr_NN files_NNS (_( Additional_JJ data_NNS
        files_NNS 6_CD ,_, 7_CD and_CC 8_CD )_) ;_: a_DT figure_NN (_( Additional_JJ data_NNS file_VBP 9_CD )_) showing_VBG
        the_DT complete_JJ dataset_NN for_IN Figure_NN 3_CD ,_, with_IN associated_VBN atr_NN ,_, cdt_NN
        and_CC gtr_NN files_NNS (_( Additional_JJ data_NNS files_NNS 10_CD ,_, 11_CD and_CC 12_CD )_) ._. Figure_NN
        3_CD contains_VBZ 686_CD transcripts_NNS whose_WP$ log_VB 
        2_CD red_JJ /_NN green_JJ ratio_NN differed_VBD from_IN the_DT mean_JJ
        expression_NN level_NN across_IN all_DT experiments_NNS by_IN at_IN least_JJS 1_CD ._. 5_CD in_IN
        at_IN least_JJS three_CD experiments_NNS of_IN the_DT treatment_NN series_NN ._. The_DT
        analysis_NN was_VBD based_VBN on_IN 2_CD ,_, 862_CD transcripts_NNS that_WDT differed_VBD
        significantly_RB between_IN proliferating_VBG and_CC confluent_NN cells_NNS and_CC
        between_IN fibroblasts_NNS derived_VBN from_IN AIS-affected_NNP individuals_NNS
        and_CC normal_JJ male_JJ foreskin_NN ,_, respectively_RB ,_, as_IN identified_VBN by_IN
        SAM_NNP analysis_NN of_IN the_DT treatment_NN series_NN ._. The_DT complete_JJ 2_CD ,_, 862_CD
        genes_NNS are_VBP displayed_VBN in_IN two_CD further_JJ figures_NNS (_( Additional_JJ data_NNS
        files_NNS 13_CD and_CC 14_CD )_) with_IN associated_VBN atr_NN ,_, cdt_NN and_CC gtr_NN files_NNS
        (_( Additional_JJ data_NNS files_NNS 15_CD ,_, 16_CD and_CC 17_CD )_) ._. All_DT files_NNS are_VBP also_RB
        available_JJ online_NN at_IN [_NN 36_CD ]_NN ._.
        Additional_JJ data_NNS file_VBP 1_CD
        An_DT additional_JJ figure_NN showing_VBG the_DT complete_JJ dataset_NN for_IN
        Figure_NN 1_CD
        Unsupervised_NNP hierarchical_JJ cluster_NN analysis_NN of_IN genes_NNS and_CC
        experiments_NNS of_IN 9_CD normal_JJ genital_JJ skin_NN fibroblast_NN lines_NNS
        (_( penile_NN foreskin_NN )_) and_CC 5_CD AIS_NNP genital_JJ skin_NN fibroblast_NN lines_NNS
        (_( labia_NN majora_NN )_) ._. Only_RB transcripts_NNS whose_WP$ log_VB 2_CD red_JJ /_NN green_JJ
        ratio_NN differed_VBD from_IN the_DT mean_JJ expression_NN level_NN across_IN all_DT
        ex-periments_JJ by_IN at_IN least_JJS 1_CD ._. 1_CD in_IN at_IN least_JJS three_CD experiments_NNS
        are_VBP displayed_VBN (_( 620_CD cDNAs_NNS )_) ._. The_DT dendro-gram_JJ of_IN the_DT array_NN
        experiments_NNS reflects_VBZ the_DT similarity_NN of_IN the_DT samples_NNS with_IN
        respect_NN to_TO their_PRP$ gene_NN expression_NN patterns_NNS ._. F_NN =_SYM female_JJ
        external_JJ genitalia_NN ,_, M_NNP =_SYM normal_JJ male_JJ external_JJ genitalia_NN ,_,
        NORM_NNP =_SYM normal_JJ male_JJ control_NN ,_, AIS_NNP 4_CD =_SYM AIS_NNP with_IN predominantly_RB
        female_JJ phenotype_NN (_( slight_JJ enlargement_NN of_IN the_DT clitoris_NNS )_) ,_, CAIS_NNP
        =_SYM complete_JJ androgen_NN insensitivity_NN syndrome_NN ._. Increasing_VBG red_JJ
        intensity_NN cor-responds_JJ to_TO increased_VB gene_NN expression_NN levels_NNS
        compared_VBN to_TO the_DT mean_NN log_NN 2_CD red_JJ /_NN green_JJ ratio_NN for_IN each_DT gene_NN ;_:
        increasing_VBG green_JJ intensity_NN corresponds_NNS to_TO decreased_VBD gene_NN
        expression_NN levels_NNS ._. The_DT scale_NN ranges_NNS from_IN -_: 8_CD to_TO +_NN 8_CD in_IN log_NN 2_CD
        space_NN ._. (_( Complete_JJ dataset_NN for_IN Figure_NN 1_CD ._. )_) ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 2_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 1_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 1_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 3_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 1_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 1_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 4_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 1_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 1_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 5_CD
        An_DT additional_JJ figure_NN showing_VBG the_DT complete_JJ dataset_NN for_IN
        Figure_NN 2_CD
        Hierarchical_NNP cluster_NN analysis_NN of_IN genes_NNS and_CC experiments_NNS
        based_VBN on_IN cDNAs_NNS identified_VBN as_IN being_VBG significantly_RB different_JJ
        in_IN expression_NN between_IN normal_JJ genital_JJ skin_NN fibroblasts_NNS and_CC
        genital_JJ skin_NN fibroblasts_NNS of_IN female_JJ patients_NNS with_IN AIS_NNP ._. The_DT
        left_VBN panel_NN shows_VBZ an_DT overview_NN of_IN 472_CD of_IN the_DT total_NN of_IN 487_CD
        significant_JJ transcripts_NNS that_WDT showed_VBD measurable_JJ expression_NN
        across_IN at_IN least_JJS 80_CD %_NN of_IN 24_CD ex-periments_JJ ._. The_DT color_NN code_NN of_IN
        the_DT dendrogram_NN and_CC the_DT sample_NN names_NNS represent_VBP the_DT origin_NN of_IN
        the_DT fibroblast_NN strains_NNS ._. The_DT scale_NN ranges_NNS from_IN -_: 4_CD to_TO +_NN 4_CD in_IN
        log_NN 2_CD space_NN ._. (_( Complete_JJ dataset_NN for_IN Figure_NN 2_CD ._. )_)
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 6_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 2_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 2_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 7_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 2_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 2_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 8_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 2_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 2_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 9_CD
        An_DT additional_JJ figure_NN showing_VBG the_DT complete_JJ dataset_NN for_IN
        Figure_NN 3_CD
        Hierarchical_NNP cluster_NN analysis_NN of_IN genes_NNS and_CC experiments_NNS
        with_IN different_JJ DHT_NNP treatment_NN regimens_NNS ._. Shown_NNP are_VBP the_DT 2862_CD
        transcripts_NNS that_WDT distinguish_VB between_IN normal_JJ genital_JJ skin_NN
        fibroblasts_NNS and_CC gonadal_NN fibroblasts_NNS from_IN 46_CD ,_, XY_NNP female_JJ AIS_NNP
        patients_NNS ,_, and_CC between_IN proliferating_VBG and_CC confluent_NN
        fibroblasts_NNS ._. The_DT color_NN code_NN in_IN the_DT dendrogram_NN depicts_VBZ the_DT
        origin_NN of_IN the_DT fibroblast_NN cultures_NNS ._. The_DT gray_JJ and_CC white_JJ bars_NNS
        on_IN top_NN of_IN the_DT cluster_NN indicate_VBP the_DT proliferation_NN state_NN of_IN
        the_DT samples_NNS ._. On_IN the_DT right_NN ,_, the_DT regions_NNS of_IN the_DT cluster_NN
        diagram_NN are_VBP indicated_VBN which_WDT differentiate_VB between_IN normal_JJ
        and_CC AIS-derived_NNP fibroblasts_NNS ,_, and_CC proliferating_VBG and_CC
        confluent_NN cells_NNS ,_, respectively_RB ._. No_DT differences_NNS in_IN transcript_NN
        levels_NNS could_MD be_VB discerned_JJ between_IN DHT_NNP treated_VBD and_CC control_NN
        cells_NNS in_IN either_DT normal_JJ foreskin_NN fibroblasts_NNS or_CC fibroblasts_NNS
        from_IN AIS_NNP affected_VBD 46_CD ,_, XY_NNP females_NNS ._. The_DT scale_NN ranges_NNS from_IN -_: 8_CD
        to_TO +_NN 8_CD in_IN log_NN 2_CD space_NN ._. (_( Complete_JJ dataset_NN for_IN Figure_NN 3_CD ._. )_)
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 10_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 3_CD
        Array_NNP tree_NN correlations_NNS for_IN Figure_NN 3_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 11_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 3_CD
        Complete_JJ data_NNS table_NN for_IN Figure_NN 3_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 12_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 3_CD
        Gene_NNP tree_NN correlations_NNS for_IN Figure_NN 3_CD ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 13_CD
        Hierarchical_NNP cluster_NN analysis_NN of_IN genes_NNS and_CC experiments_NNS
        with_IN different_JJ DHT_NNP treatment_NN regimens_NNS
        Upper_NNP half_NN of_IN Figure_NN ._. Hierarchical_NNP cluster_NN analysis_NN of_IN
        genes_NNS and_CC experiments_NNS with_IN different_JJ DHT_NNP treatment_NN
        regimens_NNS ._. Shown_NNP are_VBP the_DT 2862_CD transcripts_NNS that_WDT distinguish_VB
        between_IN normal_JJ genital_JJ skin_NN fibroblasts_NNS and_CC gonadal_NN
        fibroblasts_NNS from_IN 46_CD ,_, XY_NNP female_JJ AIS_NNP patients_NNS ,_, and_CC between_IN
        proliferating_VBG and_CC confluent_NN fibroblasts_NNS ._. The_DT color_NN code_NN in_IN
        the_DT dendrogram_NN depicts_VBZ the_DT origin_NN of_IN the_DT fibroblast_NN
        cultures_NNS ._. The_DT gray_JJ and_CC white_JJ bars_NNS on_IN top_NN of_IN the_DT cluster_NN
        indicate_VBP the_DT proliferation_NN state_NN of_IN the_DT samples_NNS ._. On_IN the_DT
        right_NN ,_, the_DT regions_NNS of_IN the_DT cluster_NN diagram_NN are_VBP indicated_VBN
        which_WDT differentiate_VB between_IN normal_JJ and_CC AIS-derived_NNP
        fibroblasts_NNS ,_, and_CC proliferating_VBG and_CC confluent_NN cells_NNS ,_,
        respectively_RB ._. No_DT differences_NNS in_IN transcript_NN levels_NNS could_MD be_VB
        discerned_JJ between_IN DHT_NNP treated_VBD and_CC control_NN cells_NNS in_IN either_DT
        normal_JJ foreskin_NN fibroblasts_NNS or_CC fibroblasts_NNS from_IN AIS_NNP
        affected_VBD 46_CD ,_, XY_NNP females_NNS ._. The_DT scale_NN ranges_NNS from_IN -_: 8_CD to_TO +_NN 8_CD in_IN
        log_NN 2_CD space_NN ._. Complete_JJ dataset_NN from_IN which_WDT Figure_NN 3_CD was_VBD
        created_VBN ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 14_CD
        Hierarchical_NNP cluster_NN analysis_NN of_IN genes_NNS and_CC experiments_NNS
        with_IN different_JJ DHT_NNP treatment_NN regimens_NNS ._.
        Lower_JJR half_NN of_IN Figure_NN ._. Hierarchical_NNP cluster_NN analysis_NN of_IN
        genes_NNS and_CC experiments_NNS with_IN different_JJ DHT_NNP treatment_NN
        regimens_NNS ._. Shown_NNP are_VBP the_DT 2862_CD transcripts_NNS that_WDT distinguish_VB
        between_IN normal_JJ genital_JJ skin_NN fibroblasts_NNS and_CC gonadal_NN
        fibroblasts_NNS from_IN 46_CD ,_, XY_NNP female_JJ AIS_NNP patients_NNS ,_, and_CC between_IN
        proliferating_VBG and_CC confluent_NN fibroblasts_NNS ._. The_DT color_NN code_NN in_IN
        the_DT dendrogram_NN depicts_VBZ the_DT origin_NN of_IN the_DT fibroblast_NN
        cultures_NNS ._. The_DT gray_JJ and_CC white_JJ bars_NNS on_IN top_NN of_IN the_DT cluster_NN
        indicate_VBP the_DT proliferation_NN state_NN of_IN the_DT samples_NNS ._. On_IN the_DT
        right_NN ,_, the_DT regions_NNS of_IN the_DT cluster_NN diagram_NN are_VBP indicated_VBN
        which_WDT differentiate_VB between_IN normal_JJ and_CC AIS-derived_NNP
        fibroblasts_NNS ,_, and_CC proliferating_VBG and_CC confluent_NN cells_NNS ,_,
        respectively_RB ._. No_DT differences_NNS in_IN transcript_NN levels_NNS could_MD be_VB
        discerned_JJ between_IN DHT_NNP treated_VBD and_CC control_NN cells_NNS in_IN either_DT
        normal_JJ foreskin_NN fibroblasts_NNS or_CC fibroblasts_NNS from_IN AIS_NNP
        affected_VBD 46_CD ,_, XY_NNP females_NNS ._. The_DT scale_NN ranges_NNS from_IN -_: 8_CD to_TO +_NN 8_CD in_IN
        log_NN 2_CD space_NN ._. Complete_JJ dataset_NN from_IN which_WDT Figure_NN 3_CD ._. was_VBD
        created_VBN ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 15_CD
        Array_NNP tree_NN correlations_NNS for_IN the_DT entire_JJ dataset_NN
        Array_NNP tree_NN correlations_NNS for_IN the_DT entire_JJ dataset_NN ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 16_CD
        Complete_JJ data_NNS table_NN for_IN the_DT entire_JJ dataset_NN
        Complete_JJ data_NNS table_NN for_IN the_DT entire_JJ dataset_NN ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 17_CD
        Gene_NNP tree_NN correlations_NNS for_IN the_DT entire_JJ dataset_NN
        Gene_NNP tree_NN correlations_NNS for_IN the_DT entire_JJ dataset_NN ._.
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
      
    
  
